Cargando…
Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report
INTRODUCTION: Osteonecrosis of the jaw is a serious side effect in patients receiving nitrogen-containing bisphosphonates intravenously due to malignant diseases. Albeit far less frequently, osteonecrosis of the jaw has also been reported to occur due to the oral administration of nitrogen-containin...
Autores principales: | Otto, Sven, Sotlar, Karl, Ehrenfeld, Michael, Pautke, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195106/ https://www.ncbi.nlm.nih.gov/pubmed/21943059 http://dx.doi.org/10.1186/1752-1947-5-477 |
Ejemplares similares
-
Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011) -
Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Otto, Sven, et al.
Publicado: (2021) -
Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients
por: Jung, Sung-mok, et al.
Publicado: (2018) -
Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate
por: Figueiredo, Marília A., et al.
Publicado: (2020) -
Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates
por: Lorusso, L., et al.
Publicado: (2021)